Image

Physiologic Changes of Posterior Ocular Segment During the Menstrual Cycle

Recruiting
25 - 40 years of age
Female
Phase N/A

Powered by AI

Overview

Changes of luteinizing hormone (LH), estrogen and progesterone during the menstrual cycle influence the ocular physiology in both anterior and posterior segments. From the literature review, there were no significant differentiation in tear physiology, anterior chamber dept, lens thickness and refractive status. Some studies demonstrated then the central corneal thickness was thinner in the follicular phase, but this is non-conclusive. Advance in ophthalmic technologies provide few studies of posterior segment changes during the menstrual cycle, however, there were quite difference in methodology such as detection methods of ovulation.

Description

There were 2 studies of posterior segment changes during the menstrual cycle. Akar et al showed significant decrease of neuroretinal rim area and increase of cupt area in late luteal phase. Ulas et al found that choroidal thickness was significant thicker in mid-luteal phase. However, the study of retinal vascular density by optical coherence tomography angiography (OCTA) during the menstrual cycle has never been published before.

Eligibility

Inclusion Criteria:

  • Female with age 25-40 yr
  • Normal body mass index (18.5-24.9)
  • Regular menstrual cycle (28-32 days)
  • Written informed consent

Exclusion Criteria:

  • Pregnant women
  • Lactating women
  • Having childbirth or miscarriage within 6 months
  • Systemic diseases which need taking the regular medication
  • History of ocular disease such as glaucoma, retinal vascular diseases and macular disease
  • History of hormonal taking such as oral contraceptive pills within 6 months
  • History of intraocular laser and intraocular surgery
  • Refractive error; spherical equivalent >4 diopters
  • Can not taking the images by Optovue® such as spine diseases

Withdrawal criteria

  • Pregnancy detection during the study period
  • Receiving sex hormone during the study period such as emergency contraceptive pills

Study details

Retinal Vascular

NCT04731207

Khon Kaen University

14 October 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.